This is a phase 4, single center, randomized, open-labeled, cross-over design study. The primary objective of the study is to compare effect of dapagliflozine and metformin on endothelial function. Subjects are randomized to initial metformin or initial dapagliflozin group and maintained initial treatment for 8 weeks. During that period, dose of dapagliflozin is maintained 10mg/day and metformin can be titrated upto 2000 mg/day. After 1 weeks of washout period, 8 weeks' cross-over is followed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
22
Boramae medical center
Seoul, South Korea
RECRUITINGReactive hyperemic index to measure endothelial function
endothelial function
Time frame: 8 weeks
N-acetyl-β-D-glucosaminidase as a measure of renal tubular injury
renal tubular injury
Time frame: 8 week
Urine albumin excretion ratio
Urine albumin excretion
Time frame: 8 week
Urine β2 microglobulin
Time frame: 8 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.